Your browser is no longer supported. Please, upgrade your browser.
SUPN Supernus Pharmaceuticals, Inc. daily Stock Chart
SUPN [NASD]
Supernus Pharmaceuticals, Inc.
Index- P/E19.45 EPS (ttm)2.01 Insider Own0.90% Shs Outstand51.11M Perf Week4.41%
Market Cap2.00B Forward P/E16.93 EPS next Y2.31 Insider Trans0.00% Shs Float50.51M Perf Month4.49%
Income108.50M PEG0.53 EPS next Q0.27 Inst Own98.60% Short Float9.65% Perf Quarter-13.32%
Sales381.40M P/S5.24 EPS this Y-28.70% Inst Trans-0.28% Short Ratio8.26 Perf Half Y-9.60%
Book/sh8.08 P/B4.84 EPS next Y24.93% ROA13.10% Target Price59.67 Perf Year-0.76%
Cash/sh5.48 P/C7.13 EPS next 5Y37.00% ROE27.60% 52W Range30.05 - 61.25 Perf YTD17.70%
Dividend- P/FCF15.25 EPS past 5Y19.70% ROI24.50% 52W High-36.16% Beta1.61
Dividend %- Quick Ratio2.70 Sales past 5Y189.70% Gross Margin96.00% 52W Low30.12% ATR1.38
Employees422 Current Ratio2.80 Sales Q/Q28.10% Oper. Margin36.40% RSI (14)60.95 Volatility3.05% 3.70%
OptionableYes Debt/Eq0.77 EPS Q/Q73.50% Profit Margin25.90% Rel Volume1.46 Prev Close38.24
ShortableYes LT Debt/Eq0.77 EarningsFeb 26 AMC Payout0.00% Avg Volume589.97K Price39.10
Recom1.80 SMA204.46% SMA507.10% SMA200-15.94% Volume860,340 Change2.25%
Nov-12-18Reiterated B. Riley FBR Buy $68 → $65
Jan-18-18Reiterated B. Riley FBR, Inc. Buy $54
Dec-28-17Reiterated B. Riley FBR, Inc. Buy $50 → $54
Dec-04-17Upgrade Janney Neutral → Buy
Nov-08-17Upgrade Stifel Hold → Buy $47
Oct-19-17Initiated FBR & Co. Buy $53
Sep-19-17Downgrade Stifel Buy → Hold $47
Jul-17-17Downgrade Piper Jaffray Overweight → Neutral
Jul-14-17Initiated Janney Neutral
Jun-01-17Upgrade Piper Jaffray Neutral → Overweight
Jul-18-16Downgrade Piper Jaffray Overweight → Neutral
Jul-18-16Downgrade Northland Capital Outperform → Market Perform
Feb-08-16Upgrade Jefferies Hold → Buy
Nov-05-15Reiterated Northland Capital Outperform $26 → $27
Oct-28-15Initiated Northland Capital Outperform $26
Jun-18-15Upgrade Jefferies Hold → Buy $11 → $18
Jun-18-15Reiterated Stifel Buy $15 → $22
Jun-12-15Initiated Sun Trust Rbsn Humphrey Buy $30
Jun-09-15Initiated Guggenheim Buy $21
Mar-14-14Reiterated Stifel Buy $12 → $14
Feb-12-19 04:15PM  Supernus to Host Fourth Quarter and Full Year 2018 Earnings Conference Call GlobeNewswire
Feb-02-19 09:21AM  An Intrinsic Calculation For Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shows Its 45.76% Undervalued Simply Wall St.
09:12AM  3 Top Small-Cap Stocks to Buy Right Now Motley Fool
Jan-10-19 09:30AM  MYL vs. SUPN: Which Stock Is the Better Value Option? Zacks
06:23AM  Does Market Volatility Impact Supernus Pharmaceuticals, Inc.s (NASDAQ:SUPN) Share Price? Simply Wall St.
Dec-28-18 11:01AM  Edited Transcript of SUPN earnings conference call or presentation 7-Nov-18 2:00pm GMT Thomson Reuters StreetEvents
Dec-21-18 04:15PM  Supernus to Present at the 2019 J.P. Morgan Healthcare Conference GlobeNewswire -5.63%
Dec-20-18 10:57AM  Supernus Pharma's ADHD drug meets main goal in study on adolescents Reuters
09:56AM  Hedge Funds Arent Crazy About Supernus Pharmaceuticals Inc (SUPN) Anymore Insider Monkey
07:12AM  Supernus Pharma's ADHD drug meets main goal in late-stage trial Reuters
07:00AM  Supernus Announces Positive Results from Phase III Study For SPN-812 in Adolescents with ADHD GlobeNewswire
Dec-16-18 09:13AM  Why We Think Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Could Be Worth Looking At Simply Wall St.
Dec-14-18 04:02PM  Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR® Label to Include Monotherapy GlobeNewswire
Dec-11-18 06:00AM  3 Top Biotech Stocks to Buy in December Motley Fool
Dec-06-18 12:53PM  This Index Of Leading Stocks Falls Into A Bear Market As Boeing Stings Dow Jones Investor's Business Daily -11.89%
12:33PM  Supernus Pharma's ADHD treatment fails to impress; shares fall Reuters
11:13AM  Here's Why Supernus Pharmaceuticals Is Sinking Today Motley Fool
08:00AM  Consolidated Research: 2018 Summary Expectations for TD Ameritrade Holding, Supernus Pharmaceuticals, Akcea Therapeutics, Dell Technologies, iRobot, and Pegasystems Fundamental Analysis, Key Performance Indications GlobeNewswire
07:56AM  The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering Benzinga
07:11AM  Supernus Pharma's ADHD treatment succeeds in two late-stage studies Reuters
07:00AM  Supernus Announces Positive Results from Two Phase III Studies For SPN-812 in Children with ADHD GlobeNewswire
Dec-05-18 04:12PM  Supernus Schedules Conference Call to Present Topline Results of Two Phase III Studies for SPN-812 in Children with ADHD GlobeNewswire
Dec-04-18 07:00AM  Today's Research Reports on Trending Tickers: Incyte and Supernus Pharmaceuticals ACCESSWIRE -5.83%
Nov-30-18 04:29PM  Stock Market Stages Bullish Reversal To Cap Week With Big Gains Investor's Business Daily +5.97%
Nov-29-18 06:55AM  Today's Research Reports on Trending Tickers: Heron Therapeutics and Supernus Pharmaceuticals ACCESSWIRE
Nov-15-18 11:06AM  What Should Investors Know About Supernus Pharmaceuticals Incs (NASDAQ:SUPN) Future? Simply Wall St.
Nov-13-18 12:13PM  5 Sizzling Small-Cap Stocks to Buy Today InvestorPlace
Nov-07-18 04:39PM  Supernus to Present at Three November Healthcare Conferences GlobeNewswire +8.50%
08:24AM  3 Top Biotech Stocks to Buy in November Motley Fool
Nov-06-18 07:35PM  Supernus Pharmaceuticals (SUPN) Tops Q3 Earnings and Revenue Estimates Zacks
06:32PM  Supernus: 3Q Earnings Snapshot Associated Press
04:15PM  Supernus Announces Third Quarter 2018 Financial Results and Record Quarterly Revenue GlobeNewswire
Oct-26-18 08:25AM  Recent Analysis Shows Supernus Pharmaceuticals, GDS HOLDINGS, Golden Ocean Group, Golar LNG, Endo International plc, and 51job Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Oct-24-18 04:30PM  Supernus to Host Third Quarter 2018 Earnings Conference Call GlobeNewswire
Oct-15-18 08:15AM  Supernus Pharmaceuticals (SUPN): Moving Average Crossover Alert Zacks
Oct-10-18 05:17AM  New Strong Sell Stocks for October 10th Zacks
Sep-21-18 03:52PM  Did Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Create Value For Shareholders? Simply Wall St.
Sep-20-18 05:28PM  Supernus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-14-18 01:54PM  Supernus Pharmaceuticals to acquire Miami biotech for up to $185M American City Business Journals
08:38AM  The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut Benzinga
Sep-13-18 04:15PM  Supernus to Acquire Biscayne Neurotherapeutics GlobeNewswire
Sep-07-18 08:18AM  3 Top Biotech Stocks to Buy in September Motley Fool +5.24%
Sep-06-18 03:34PM  Supernus Wins Appeal on Oxtellar XR® against TWi GlobeNewswire
08:00AM  Today's Research Reports on Trending Tickers: Momenta Pharmaceuticals and Supernus Pharmaceuticals ACCESSWIRE
Sep-05-18 05:15PM  Looking For Growth? Take A Look At These Biotechnology Stocks Investor's Business Daily
Aug-29-18 04:15PM  Supernus to Present at September 2018 Wells Fargo Healthcare Conference GlobeNewswire
Aug-24-18 03:50AM  Edited Transcript of SUPN earnings conference call or presentation 8-Aug-18 1:00pm GMT Thomson Reuters StreetEvents
Aug-08-18 04:18PM  IBD 50's Supernus Pharma Topples As Key Epilepsy Drug Sales Lag Investor's Business Daily -8.72%
03:01PM  Why Supernus Pharmaceuticals, Inc. Is Falling Today Motley Fool
03:00PM  Google Owner Defies Stock Market Blues As This Internet Stock Goes En Fuego Investor's Business Daily
07:00AM  Supernus Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-18 07:05PM  Supernus Pharmaceuticals (SUPN) Surpasses Q2 Earnings Estimates Zacks
05:59PM  Supernus: 2Q Earnings Snapshot Associated Press
04:15PM  Supernus Announces Second Quarter 2018 Financial Results and Record Quarterly Revenue GlobeNewswire
Jul-25-18 04:15PM  Supernus to Host Second Quarter 2018 Earnings Conference Call GlobeNewswire
Jul-20-18 06:00AM  5 Favorite Biotech Bets Investopedia
Jul-19-18 07:50AM  Initiating Free Research Reports on Horizon Pharma and Three Other Healthcare Equities ACCESSWIRE
Jun-27-18 04:30PM  Dr. Carrolee Barlow, M.D., Ph.D., Joins Supernus Board of Directors GlobeNewswire
Jun-24-18 10:38AM  These Factors Make Supernus Pharmaceuticals Inc (NASDAQ:SUPN) A Great Investment Simply Wall St.
Jun-20-18 03:01PM  Brief Commentary On Supernus Pharmaceuticals Incs (NASDAQ:SUPN) Fundamentals Simply Wall St. +5.16%
Jun-18-18 07:05AM  Free Research Reports on Ironwood Pharma and Three More Generic Drugs Stocks ACCESSWIRE
Jun-05-18 07:55AM  Recent Analysis Shows Supernus Pharmaceuticals, R1 RCM, Golar LNG, Chemical Financial, Chipmos Technologies, and Tower Semiconductor Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jun-01-18 09:00AM  Faruqi & Faruqi, LLP is Investigating Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of its Shareholders PR Newswire
May-30-18 10:15AM  Supernus to Present at the 2018 Jefferies Healthcare Conference GlobeNewswire
May-16-18 11:10AM  Breakout Watch: Biotech Stock With 172% Growth Enters Buy Zone Investor's Business Daily
May-15-18 08:51AM  Implied Volatility Surging for Supernus (SUPN) Stock Options Zacks
May-14-18 08:00AM  Todays Research Reports on Stocks to Watch: Intrexon and Supernus Pharmaceuticals ACCESSWIRE
May-11-18 03:02PM  6 Ways To Play Biotechs As Small Stocks Score Big Gains Investor's Business Daily +14.33%
03:56AM  Edited Transcript of SUPN earnings conference call or presentation 9-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-08-18 06:15PM  Supernus: 1Q Earnings Snapshot Associated Press
04:40PM  Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue GlobeNewswire
Apr-24-18 04:15PM  Supernus to Host First Quarter 2018 Earnings Conference Call GlobeNewswire
Apr-21-18 07:16AM  3 Top Biotech Stocks to Buy Right Now Motley Fool
Apr-19-18 11:55AM  Harry Boxers biotech-stock breakouts to watch MarketWatch
Apr-12-18 12:02PM  Top 3 Growth Stocks For The Month Simply Wall St.
Apr-11-18 07:45AM  Factors of Influence in 2018, Key Indicators and Opportunity within Harmonic, Supernus Pharmaceuticals, America First Multifamily Investors, Ballard Power, ServiceSource International, and Materialise NV New Research Emphasizes Economic Growth GlobeNewswire
Mar-30-18 01:26AM  Edited Transcript of SUPN earnings conference call or presentation 28-Feb-18 2:00pm GMT Thomson Reuters StreetEvents
Mar-15-18 12:07PM  Supernus getting Maryland incentives in HQ relocation, plans to add 160 jobs American City Business Journals
06:55AM  Supernus Announces Pricing of $350 Million Private Offering of 0.625% Convertible Senior Notes GlobeNewswire
Mar-14-18 08:10AM  Research Report Identifies Supernus Pharmaceuticals, Celestica, Global Blood Therapeutics, BioTime, CyberArk Software, and Tivity Health, Inc. with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-13-18 04:01PM  Supernus Announces Proposed Private Offering of $350 Million of Convertible Senior Notes GlobeNewswire
Mar-07-18 06:48PM  Supernus Pharmaceuticals inks deal for new, expanded headquarters American City Business Journals
Mar-06-18 04:15PM  Supernus to Present at the 2018 Cowen Health Care Conference GlobeNewswire
Mar-02-18 09:48AM  Supernus Pharmaceuticals Inc (SUPN) Files 10-K for the Fiscal Year Ended on December 31, 2017 GuruFocus.com
Feb-28-18 07:15AM  Supernus Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
05:04AM  Supernus beats Street 4Q forecasts Associated Press
Feb-27-18 04:15PM  Supernus Announces Record Full Year 2017 Financial Results, Exceeding Operating Earnings Guidance GlobeNewswire
11:31AM  Supernus Pharmaceuticals Q4 Earnings Preview Benzinga
Feb-22-18 11:02AM  Top Growth Stocks To Buy Simply Wall St.
Feb-12-18 04:15PM  Supernus to Host Fourth Quarter and Full Year 2017 Earnings Conference Call GlobeNewswire
Feb-06-18 10:22AM  See the D.C.-area stocks hit hardest in the last week American City Business Journals
Jan-22-18 08:00AM  Todays Research Reports on Trending Tickers: Supernus Pharmaceuticals and Synergy Pharmaceuticals ACCESSWIRE -5.65%
Jan-17-18 04:35PM  Supernus Pharmaceuticals Stock Is an Institutional Favorite Investopedia +8.77%
Jan-12-18 03:15PM  Supernus Mourns the Loss of Board Member William Nuerge GlobeNewswire
Jan-10-18 03:00AM  Supernus Pharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold Investor's Business Daily
Jan-08-18 03:00AM  Stocks Generating Improved Relative Strength: Supernus Pharmaceuticals Investor's Business Daily
Jan-02-18 04:15PM  Supernus to Present at the 2018 J.P. Morgan Healthcare Conference GlobeNewswire
08:07AM  See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc. Markit
Dec-29-17 03:00AM  Supernus Pharmaceuticals Shows Rising Price Performance With Jump To 81 RS Rating Investor's Business Daily
Dec-27-17 06:00AM  4 Top Pharmaceutical Stocks for 2018 Investopedia
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy. The company's product candidates comprise SPN-810, a molindone hydrochloride that is in Phase III clinical trial for the treatment of impulsive aggression in patients with attention deficit hyperactivity disorder (ADHD); and SPN-812, a viloxazine hydrochloride, which is in Phase III clinical trial that is used for the treatment of ADHD. It also develops SPN-809, a viloxazine hydrochloride, which is in Phase II ready clinical trial for the treatment of depression. The company markets its products through wholesalers and pharmaceutical distributors. Supernus Pharmaceuticals, Inc. was founded in 2005 and is based in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PATRICK GREGORY SVP, Chief Financial OfficerJul 02Option Exercise9.1935,000321,75090,975Jul 03 03:27 PM
PATRICK GREGORY SVP, Chief Financial OfficerJul 02Sale56.6335,0001,981,91455,975Jul 03 03:27 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOJun 29Sale59.904,393263,1530Jun 29 06:03 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOJun 28Option Exercise9.132952,6937,795Jun 29 06:03 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOJun 28Sale59.943,402203,8994,393Jun 29 06:03 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOJun 21Option Exercise9.137,20565,78214,705Jun 22 05:30 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOJun 21Sale60.007,205432,3237,500Jun 22 05:30 PM
Schwabe Stefan K.F.Executive VP R&D, CMOJun 18Option Exercise8.7960,000527,60061,967Jun 19 05:51 PM
Schwabe Stefan K.F.Executive VP R&D, CMOJun 18Sale54.3960,0003,263,3521,967Jun 19 05:51 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMay 15Option Exercise9.147,86871,87515,000May 16 05:05 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMay 15Sale57.937,868455,7597,500May 16 05:05 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMay 11Option Exercise8.6042,132362,50032,500May 14 03:09 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMay 11Sale54.4947,1322,568,1697,500May 14 03:09 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMay 10Option Exercise7.9020,000158,00032,500May 14 03:09 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMay 10Sale49.8820,000997,54412,500May 14 03:09 PM
Vaughn VictorSr. VP of Sales & MarketingApr 19Option Exercise25.307,850198,60517,194Apr 20 04:53 PM
Vaughn VictorSr. VP of Sales & MarketingApr 19Sale49.037,850384,8559,344Apr 20 04:53 PM
Vaughn VictorSr. VP of Sales & MarketingApr 18Option Exercise17.6010,000176,00019,344Apr 20 04:53 PM
Vaughn VictorSr. VP of Sales & MarketingApr 18Sale47.0610,000470,6179,344Apr 20 04:53 PM
Vaughn VictorSr. VP of Sales and MarketingApr 05Option Exercise10.3660,000621,63835,594Apr 09 12:12 PM
Vaughn VictorSr. VP of Sales and MarketingApr 05Sale45.3360,0002,719,7709,344Apr 09 12:12 PM